Surrogate endpoints in cost-effectiveness analysis for use in health technology assessment - a qualitative analysis
{{output}}
Objectives: The use of surrogate endpoints poses challenges to health technology assessment (HTA) agencies and payers when informing the clinical and cost-effectiveness of health technologies. Decision makers often need to make r... ...
